Forma Therapeutics

Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal
Yahoo/Reuters
Thu, 09/1/22 - 10:49 am
Novo Nordisk
Forma Therapeutics
M&A
blood disorders
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA
Fierce Biotech
Tue, 08/2/22 - 11:30 pm
Rigel Pharmaceuticals
Forma Therapeutics
olutasidenib
leukemia
FDA
4 Biotechs That Were Winners at ASH
Motley Fool
Mon, 01/3/22 - 10:38 am
ASH2021
Bristol Myers Squibb
Agios Pharmaceuticals
Forma Therapeutics
Bluebird Bio
sickle cell disease
Multiple Myeloma
Forma builds case for FT-4202 in competitive sickle cell space
Fierce Biotech
Tue, 03/30/21 - 11:56 am
Forma Therapeutics
sickle cell disease
FT-4202
clinical trials
ASH 2020 – Forma gets an early edge over Agios in sickle cell disease
EP Vantage
Tue, 12/8/20 - 10:30 am
ASH2020
Forma Therapeutics
Agios
sickle cell disease
FT-4202
Forma Therapeutics gets European orphan drug status for FT-4202 to treat sickle cell disease
Pharmaceutical Business Review
Thu, 11/12/20 - 10:40 am
Forma Therapeutics
orphan drugs
Europe
FT-4202
sickle cell disease
Forma takes aim at Agios with new AML complete remission data
Endpoints
Mon, 10/26/20 - 11:01 am
Forma Therapeutics
sickle cell disease
clinical trials
Agios
AML
Forma Therapeutics nabs new R&D execs as it plots late-stage sickle cell test next year
Fierce Biotech
Tue, 09/15/20 - 11:32 pm
Forma Therapeutics
R&D
sickle cell disease
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
Fri, 06/19/20 - 11:27 am
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut
Endpoints
Mon, 06/1/20 - 10:48 am
IPOs
NASDAQ
Forma Therapeutics
Bristol-Myers Squibb
COVID-19
Celgene Broadens Forma Deal, Adding $195M More for Drug R&D
Xconomy
Wed, 08/30/17 - 09:37 am
Celgene
Forma Therapeutics
R&D
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Celgene doubles down on Forma with a $600M discovery deal tied to a buyout option
Fierce Biotech
Tue, 04/1/14 - 08:15 am
Celgene
Forma Therapeutics
drug discovery
M&A
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wed, 09/7/11 - 11:28 am
Blueprint Medicines
Cerulean
Cerenis Therapeutics
Epizyme
Forma Therapeutics
Intrexon
Merrimack Pharmaceuticals
f-star
Pfenex
Pearl Therapeutics
Reata
Selecta
Rib-X Pharmaceuticals
Tesaro
Theraclone